Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Proteolytic cleavage of Beclin 1 exacerbates neurodegeneration.

Bieri G, Lucin KM, O'Brien CE, Zhang H, Villeda SA, Wyss-Coray T.

Mol Neurodegener. 2018 Dec 29;13(1):68. doi: 10.1186/s13024-018-0302-4.

2.

Microglial complement receptor 3 regulates brain Aβ levels through secreted proteolytic activity.

Czirr E, Castello NA, Mosher KI, Castellano JM, Hinkson IV, Lucin KM, Baeza-Raja B, Ryu JK, Li L, Farina SN, Belichenko NP, Longo FM, Akassoglou K, Britschgi M, Cirrito JR, Wyss-Coray T.

J Exp Med. 2017 Apr 3;214(4):1081-1092. doi: 10.1084/jem.20162011. Epub 2017 Mar 15.

3.

Erratum to: Network-driven plasma proteomics expose molecular changes in the Alzheimer's brain.

Jaeger PA, Lucin KM, Britschgi M, Vardarajan B, Huang RP, Kirby ED, Abbey R, Boeve BF, Boxer AL, Farrer LA, Finch N, Graff-Radford NR, Head E, Hofree M, Huang R, Johns H, Karydas A, Knopman DS, Loboda A, Masliah E, Narasimhan R, Petersen RC, Podtelezhnikov A, Pradhan S, Rademakers R, Sun CH, Younkin SG, Miller BL, Ideker T, Wyss-Coray T.

Mol Neurodegener. 2016 May 23;11(1):42. No abstract available.

4.

Network-driven plasma proteomics expose molecular changes in the Alzheimer's brain.

Jaeger PA, Lucin KM, Britschgi M, Vardarajan B, Huang RP, Kirby ED, Abbey R, Boeve BF, Boxer AL, Farrer LA, Finch N, Graff-Radford NR, Head E, Hofree M, Huang R, Johns H, Karydas A, Knopman DS, Loboda A, Masliah E, Narasimhan R, Petersen RC, Podtelezhnikov A, Pradhan S, Rademakers R, Sun CH, Younkin SG, Miller BL, Ideker T, Wyss-Coray T.

Mol Neurodegener. 2016 Apr 26;11:31. doi: 10.1186/s13024-016-0095-2. Erratum in: Mol Neurodegener. 2016;11(1):42.

5.

Antiviral drug ganciclovir is a potent inhibitor of microglial proliferation and neuroinflammation.

Ding Z, Mathur V, Ho PP, James ML, Lucin KM, Hoehne A, Alabsi H, Gambhir SS, Steinman L, Luo J, Wyss-Coray T.

J Exp Med. 2014 Feb 10;211(2):189-98. doi: 10.1084/jem.20120696. Epub 2014 Feb 3.

6.

Microglial beclin 1 regulates retromer trafficking and phagocytosis and is impaired in Alzheimer's disease.

Lucin KM, O'Brien CE, Bieri G, Czirr E, Mosher KI, Abbey RJ, Mastroeni DF, Rogers J, Spencer B, Masliah E, Wyss-Coray T.

Neuron. 2013 Sep 4;79(5):873-86. doi: 10.1016/j.neuron.2013.06.046.

7.

Targeting autophagy for disease therapy.

Lucin KM, Wyss-Coray T.

Nat Biotechnol. 2013 Apr;31(4):322-3. doi: 10.1038/nbt.2554. No abstract available.

PMID:
23563430
8.

The ageing systemic milieu negatively regulates neurogenesis and cognitive function.

Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G, Stan TM, Fainberg N, Ding Z, Eggel A, Lucin KM, Czirr E, Park JS, Couillard-Després S, Aigner L, Li G, Peskind ER, Kaye JA, Quinn JF, Galasko DR, Xie XS, Rando TA, Wyss-Coray T.

Nature. 2011 Aug 31;477(7362):90-4. doi: 10.1038/nature10357.

9.

Regulation of amyloid precursor protein processing by the Beclin 1 complex.

Jaeger PA, Pickford F, Sun CH, Lucin KM, Masliah E, Wyss-Coray T.

PLoS One. 2010 Jun 15;5(6):e11102. doi: 10.1371/journal.pone.0011102.

10.

Immune activation in brain aging and neurodegeneration: too much or too little?

Lucin KM, Wyss-Coray T.

Neuron. 2009 Oct 15;64(1):110-22. doi: 10.1016/j.neuron.2009.08.039. Review.

11.

Stress hormones collaborate to induce lymphocyte apoptosis after high level spinal cord injury.

Lucin KM, Sanders VM, Popovich PG.

J Neurochem. 2009 Sep;110(5):1409-21. doi: 10.1111/j.1471-4159.2009.06232.x. Epub 2009 Jun 22.

12.

Impaired antibody synthesis after spinal cord injury is level dependent and is due to sympathetic nervous system dysregulation.

Lucin KM, Sanders VM, Jones TB, Malarkey WB, Popovich PG.

Exp Neurol. 2007 Sep;207(1):75-84. Epub 2007 Jun 2.

13.

Spinal cord injury triggers systemic autoimmunity: evidence for chronic B lymphocyte activation and lupus-like autoantibody synthesis.

Ankeny DP, Lucin KM, Sanders VM, McGaughy VM, Popovich PG.

J Neurochem. 2006 Nov;99(4):1073-87.

Supplemental Content

Loading ...
Support Center